Artificial Intelligence News

RSS

Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis Gets FDA Orphan Drug Designation

Insilico Medicine, a clinical-stage end-to-end generative artificial intelligence (AI)-driven drug discovery company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to INS018_055 for the treatment of Idiopathic Pulmonary Fibrosis (IPF).

9 Feb 2023

Uncovering Highly Selective Catalysts Using AI

A new study illustrated a machine learning strategy that uses sophisticated but efficient two-dimensional molecular descriptors to reliably predict highly selective asymmetric catalysts without quantum chemical computations.

8 Feb 2023

Generative AI Helps Nextech to Achieve a Breakthrough in Texture Expansion

Nextech AR Solutions Corp. NEXCF NTAR EP, an Augmented Reality, Metaverse Company and 3D model supplier for Amazon and other major ecommerce retailers and brands, is pleased to announce its has achieved with the help of generative AI a breakthrough in the field of texture expansion.

8 Feb 2023

Qatar Airways Cargo to Use FLYR's Advanced AI Technology to Optimize Cargo Forecasting and Decision Making

Qatar Airways Cargo, the world’s leading air cargo carrier, is partnering with FLYR Labs, the travel industry’s leading innovator in Artificial Intelligence (AI) for forecasting and pricing.

8 Feb 2023

Syneos Health Collaborates with Haystack Health to Improve Clinical Trials with AI

Syneos Health®, the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with Haystack Health, a Roivant Health portfolio company developing advanced Artificial Intelligence (AI) and Natural Language Processing (NLP) solutions, to improve the identification and enrollment of patients for clinical trials.

8 Feb 2023